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INTRODUCTION
Association of temporomandibular joint (TMJ) disc integrity and position with internal
derangement of the TMJ, joint pain, and dysfunction has been studied since the early 1970's.
1-4 Various treatment procedures have been advocated to reposition, repair, remove or replace
damaged discs.5-10 Surgical procedures have included TMJ arthroscopy, arthrocentesis,
discectomy and disc repair procedures, and total joint replacement.5,11-19 When discectomy
or removal of the disc was performed, autologous grafts as well as alloplastic TMJ
interpositional implants (TMJ IP) were used to provide interposing tissue between the condyle
and the temporal bone and increase joint stability.5,7,20-22 More than 20,000 TMJ IP may
have been implanted from 1974 until 1993.7,20,21,25 The most common implanted devices
were Proplast/Teflon® (Vitek, Inc., Houston, TX) and silicone rubber or Silastic® (Dow
Corning Corp., Midland, MI) since late 1960s.5,20,25-30
Proplast® is a porous form of polytetrafluoroethylene (PTFE) with an admixture of fibers of
either vitreous carbon (Proplast I) or aluminum oxide (Proplast II or PTFE-Al2O3). A porous
sheet of Proplast® is laminated to Teflon®, a dense smooth form of PTFE, to form Proplast/
Teflon®. Proplast/Teflon® implants have a high melting point (above 250°C), unusual
toughness, insolubility in all common solvents, resistance to chemical attack, anti-frictional
properties; and a modulus of elasticity (E=0.5 GPa) resembling that of bone and fibrous tissue.
20,28,37 Certain investigators 20,21,28,37 considered that the porous PTFE offered more
stability than nonporous silicone implants, and that other desirable properties were present such
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as freedom from adverse reactions, toxicological safety, rapid tissue ingrowth, and
biocompatibility. Initial studies reported that Proplast/Teflon® implants seemed to produce
pain relief and improve TMJ function.22,26,27,29,38
In the late 1980s, Proplast/Teflon® TMJ IP were found to brake or be rejected in many patients,
because of the high biomechanical forces placed on them.20,21,25,33,36,39-42 The
breakdown lead to production of fragmented particles which resulted in an immune foreign
body response21,25,39-42, causing problems ranging from severe cutaneous inflammatory
reaction in the pre-auricular and cheek areas43; to severe degenerative joint disease with
resorption and erosion of the TMJ bony structures, perforation into the middle cranial
fossa44,45,46, chronic pain, increased joint noises, TMJ hypomobility, and malocclusion. The
result was a dramatic clinical spectrum of failures for these implants.20,21,25,42-50 The
December 1991 issue of the US Foods and Drugs Administration Bulletin recommended
immediate removal of all previous TMJ Proplast/Teflon® IPs, due to the mechanical failures,
many resulting in progressive bone degeneration.31,33 The American Academy of Oral and
Maxillofacial Surgery (AAOMS), in a 1992 workshop, mandated the discontinuation of
Proplast/Teflon®IPs.31
Silicone elastomers have been extensively studied and clinically used as implants for a wide
range of purposes in various anatomic locations, such as finger, wrist, elbow, shoulder, and
metatarsal joints.20,42,51-54 Silastic® is a flexible and inert polydimethylsiloxane (silicone
rubber) with resilient properties, easily carved, readily adaptable to the TMJ, and it does not
allow tissue ingrowth.55 Silastic® implants can have 1 to 2 mm thickness and be reinforced
with Dacron (or polyethylene terephthalate) fibers.20,21 Studies25,42 advocating its use have
mentioned its ability to form a fibrous connective tissue capsule that might act as a disc
substitute. Silastic® was introduced to the medical community in 1968 as an interpositional
material for the reconstruction of arthritic or severely damaged joints in the hand after
experimental evidence showed its biocompatibility.42 Researchers37,42,51 demonstrated that
different forms of Silastic® implants became surrounded by a fibrous capsule. It was thought
that solid silicone fulfilled many of the requirements of an ideal implant material even though
occasional intracellular particles of silicone elastomer were observed inside tissue
macrophages. Silicone implants showed less mechanical stability, but 50% less gross tearing
than Proplast II implants.20,21 In 1981, silicone rubber replacement after TMJ discectomy
became popular and foreign-body giant-cell reaction (FBGCR) to the material was rarely
reported.25,42,52,53 However, reports published after 1982, demonstrated long-term
instability of this material in the TMJ, FBGCR around fragmented silicone particles, peri-
implant lymph nodes containing silicone particles, and a severe reactive synovitis, sometimes
resulting in destructive arthritis of the condyle.20,21,42,56-60 In 1992, the AAOMS issued
recommendations on the use of Silastic® TMJ IPs. They were only to be used in preventing
joint ankylosis.31 These implants were subsequently removed from the market in January
1993.
A number of research studies21,25,38-41 have previously evaluated wear debris and particle
breakdown of Silastic® and Proplast/Teflon® implants, however, no systematic study has
focused on relating implant structural failure patterns to patient clinical outcomes. There is a
lack of direct evidence associating clinical failure and implant material failure. The National
Institute of Health, in its Technology Assessment conference #19 61, proposed further studies
to determine whether the clinical failure of alloplastic implanted devices is related to the
implant material.36 Information required to evaluate and improve TMJ implants must come
from a combination of clinical data and device retrieval analysis.
The goal of this pilot study was to perform an analysis of surgically explanted Silastic® and
Proplast/Teflon® IP, to determine what breakdown factors contributed to their clinical failure,
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and compare this with patient outcomes. The hypotheses for this study were to test whether
the presence of perforation, fracture length, and the type of implant was associated with poor
clinical outcomes.
EXPERIMENTAL DESIGN & RESEARCH METHODS
This study was reviewed and approved by the University of Minnesota Institutional Review
Board for Human Subjects Research (#0502E67398). Implants, tissue samples and clinical
data, de-identified from all demographic data, were provided by the National Institute of Dental
and Craniofacial Research's Temporomandibular Joint Implant Registry and Repository
(NIDCR's TIRR, N01-DE-22635). The research project was compliant with the “Ethical
principles for medical research involving Human subjects” enunciated in the “World Medical
Association Declaration of Helsinki”.
Biological Specimens
Ten TMJ IP implants were randomly selected from surgically retrieved and archived implants
in NIDCR's TIRR. Three Silastic® and seven Proplast/Teflon® TMJ IP were obtained from
eight patients who had them unilaterally, and two who had them bilaterally. Clinical outcome
data was available in the database system of NIDCR's TIRR for these implants.
Specimens were stored based on the quantity/quality of each implant/tissue fragment (soft or
hard tissue properties). Formalin-fixed specimens were archived at room temperature,
paraformaldehyde and glutaraldehyde specimens were refrigerated at -20°C, fresh specimens
were stored frozen at -80°C, and dried specimens were stored in a vacuum desiccator. Fixed
implant specimens were thoroughly washed with distilled water prior to observation with the
stereo zoom microscope.
A Leica S6D stereo zoom microscope with the magnification of 0.63X to 4X was used to
evaluate the morphology of the failed implants. Each implant was divided into 2 regions:
peripheral and central areas. Surface perforations, including their position, and fragmentation
were documented along with the presence or absence of surface scratches. Fragmented surfaces
were examined with the help of a penetrating light source. The length of each implant fracture
was measured with a graded paper of millimeter squares (2.5mm per square) placed under a
clear plastic Petri dish. The lengths were recorded with a digital camera (Nikon Coolpix 8900)
and added for each implant.
Soft tissue specimens underwent routine histologic processing and embedding in paraffin. A
rotary microtome was used to cut 4-5μm sections for routine hematoxylin and eosin (H&E)
staining and histological analysis by light microscopy (Olympus BX 50 from Leeds Precision
Instruments, Inc., Minneapolis, MN). Two hard tissue specimens containing implant material,
stored in 4% paraformaldeyde at -20°C, were embedded in paraffin, and cut at 50μm. The
sections were then stained with toluidine blue (Stevenel's blue) and basic fuchsin (Van Gieson's
picric fuchsin stain) and examined under the light microscope.
Electron Microprobe Analysis—The five implants with granulomatous tissue were
chosen to evaluate their structural and chemical morphology using an electron microprobe.
One section approximately 1-2mm in width was cut from each of the implants. Each section
was then placed in a 0.1 mol/L phosphate buffer solution, dehydrated using increasing ethanol
concentrations, and finally left for 24 hours inside a desiccator. One additional tissue section,
showing a foreign body giant cell reaction (FBGCR) surrounding implant fragments, was
selected. This was sent to the electron microprobe facility for qualitative chemical analyses to
detect what surface elements might be present and related to the foreign body response.
Standardized mounting procedures to perform the microprobe analysis, were employed and
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are described elsewhere.39,40,57,62 The prepared microprobe mounts were examined,
analyzed and photographed with a JEOL JXA-8600 Electron Probe Microanalyzer.
For qualitative analyses, a wavelength dispersive spectrometer spectrum was collected to
identify the chemical elements present in the implants surrounded by the FBGCR. In order to
show the distribution of the elements across the surface of the implant/soft tissue samples, a
series of element maps were collected. Backscattered electron images were produced to show
variations in the number of electrons being ejected from the analyzed sample, reflecting
variations in the average atomic number. The higher the atomic number at a location, the greater
the number of backscattered electron that will be ejected.
Clinical Data
The Symptom Severity Index (SSI) and Jaw Function Questionnaire (JFQ) from the
Temporomandibular Disorder Research Diagnostic Criteria (TMD RDC) - Axis II were
selected as the clinical outcomes of interest.63-66 These questionnaires were completed by the
patients 1 to 3 months prior to the surgical procedure. Patient age was calculated at the time
of implant removal. Primary clinical outcome measures collected were the SSI and JFQ The
SSI is a reliable and valid self-report measure that was designed to assess multidimensional
symptoms in patients with chronic pain, and it was chosen because it includes the symptom
domains that are most likely to change with time and treatment. The SSI is composed of 5
single-item scales: 2 Likert rating scales for pain frequency and duration and 3 visual analog
scales for sensory intensity, affective intensity, and intolerability of pain. The JFQ was designed
to measure the impairment in function and chewing ability of the stomatognatic system. It
contains items to assess how much TMD-related pain interferes with mandibular function, i.e.,
chewing, swallowing, as well as chewing ability. The JFQ was used since it has been tested
for reliability and validity. The SSI is an appropriate measure to assess the patient's subjective
pain symptoms, and the JFQ is one of the most suitable to appraise the function and chewing
ability of the implant patient's masticatory system.63-66
Statistical Analysis
Statistical analysis of the clinical outcome data (SSI, JFQ) and implant failure data was
performed. Student t-tests were used for categorical independent variables and linear regression
was employed for continuous variables for either outcomes (SSI and JFQ). The tests were
adjusted for age and gender variables. A multivariate linear regression model was employed
to test if type of implant, presence of perforation, implant fracture length, age and gender are
related to SSI and JFQ. The independent variables were the implant type (Silastic® vs Proplast/
Teflon®), presence of implant perforation (present versus absent), length of the implant
fracture (in millimeters), age and gender. Dependent variables were the SSI and JFQ. Every
test (T-test and linear regression model with/without age and gender adjustment) was employed
again with each SSI pain component (pain sensory intensity, affective intensity, tolerability of
pain, frequency and duration) as the dependent variable.
RESULTS
The study group, composed of nine females and one male, had a mean age of 49.4 (± 11) years.
(Table 1 and 2). TMJ implants analyzed had been in place for anywhere from 15 to 25 years
prior to explantation. Implant specimens were either intact (most of the cases) or fragmented
into numerous pieces. Some samples came with attached fragments of soft blood-tinged tissues
with suspected foreign body granuloma, or fragments of hard tissue. The Proplast/Teflon®
implant samples were composed of Proplast II and all displayed a characteristic porous bright-
colored surface. Silastic® implant samples were unique with two similar shiny surfaces and
silicone gel reinforced by a Dacron matrix.
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Stereo zoom microscopy of Proplast/Teflon® IP exhibited perforations on the central aspects
of the implants. Friction traces (Fig. 1a, Table 1) were present in every direction on the smooth
side. Some edges exhibited extruded fibers. (Fig. 1c) Surface evaluation showed ductile failure
behavior and fracture/fragmentation features were commonly noted. The size of the
perforations was found to reach more than 5 mm in diameter. (Fig. 1b) Occasionally, the porous
surface appeared to be attached to red granulomatous tissue; and tearing and breakdown of the
two implant layers was observed with TMJ soft tissue observed in between. (Fig.1d) Implant
center perforations appeared to progressively open fracture lines to the periphery (Fig. 1a) and
also showed fiber extrusion. Stereo zoom microscopy of the Silastic®non-reinforced Dacron
implant showed a line of fracture and failure pattern along its width. (Fig. 2a) Two other
Silastic® implants appeared to have a large perforation in the center with multiple breakdown
lines spreading to the periphery and extrusion of Dacron fibers. (Figs. 2b and 2c)
Light microscopy of tissues attached to Proplast/Teflon® IP (H&E sections) revealed portions
of fibrous connective tissue containing implant wear debris and an associated prominent
FBGCR. Giant cells were observed surrounding large implant pieces and ingesting smaller
particles. Dense areas of collagen were present in certain areas (Figs. 3a). Undecalcified
sections of implant and tissue were stained for histomorphometric evaluation and the black
materials seen in Fig. 3b are Proplast/Teflon® and the red stained areas represent bone
ingrowth. Tissue ingrowth can also be seen in the Proplast® surface layer. (Fig. 3b) For the
Silastic® IP, tissue sections revealed a small portion of fibrous connective tissue with scattered
small deposits of an embedded translucent foreign material. Foreign body reaction composed
was not associated with this material. (Fig. 3c)
Electron Microprobe Analysis
Electron microprobe analysis (EMA) of Proplast/Teflon® IP sections revealed two different
phases. There was a large gray area of F-rich (presumably Teflon) and a Ca-phosphate phase,
which showed up as the white areas on the backscattered electron image. (Fig. 4) Element
mapping and a line profile was done in specific areas to differentiate the two phases. (Fig. 4)
The element mapping revealed large areas of F-rich material and small bright areas of Ca-
Phosphate. (Fig. 4) The line profile confirmed that the gray material is a F-rich phase,
presumably Teflon, intergrown with an Al-rich phase, and poor in Ca-phosphate; and the white
areas were Ca and P-rich phases, possibly ceramic, with residual F and Al phases. (Fig. 4)
Grooves and ridges were rarely observed in the element maps images and they might be a result
of the high intensity levels of the electron beam that damaged the surface.
A different section contained fragments of the ceramic (compound of Ca-phosphate) material
intermixed with the Teflon (areas rich in fluorine - F). (Fig.5) The sample had white irregular
shaped fragments - ceramic, which were surrounded by the flattened out gray material - Teflon.
The Teflon could be identified by its high F content. Small inclusions composed of a Fe and
Cr phase and a Bi and Al phase were also identified with EDS. (images not published)
Since a giant cell reaction surrounding the implant material was found in the histological
studies, an EMA was performed on the histological section represented in Figure 6. There are
scattered bright features and most of the larger bright ones suggest particles of Teflon. (Fig. 6)
The size of these particles varied between 20 and 230 μm. Line profile across the brighter
particles showed that these are very F-rich materials; therefore, the assumption is that it is
Teflon. (Fig. 6). Element maps for C, P and Cl were completely blank, indicating no significant
concentrations of those chemical elements are present. Small inclusions of other phases were
also present in the implant attached tissue: Al, NaCl, NaKCl, KAl silicate and CaO (or
carbonate). These inclusions were not displayed here.
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Silastic® implant sections suggest a silicon gel. (Fig. 7) However, inside the gel were small
patches of fibrous material in the element maps (Fig. 7). The fibrous materials were rich in F
and contained an abundance of Ti inclusions (Fig. 7). The gel was a heterogeneous material
well visualized in the element maps. The line profile showed a mix of two phases, one rich in
Si and oxygen; and the other phase was rich in F, C and N (Fig. 7).
CLINICAL AND STATISTICAL DATA
SSI data is seen in Table 1. The reported temporomandibular/facial pain complaints varied in
location, with the temple pain being the most prevalent (60%), and jaw and jaw joint pain (30%
each). JFQ values are seen in Table 1. Failure measures for each implant were recorded in
Table 1.
Mean age and standard deviations were similar between the implant groups. Considerable
difference in the outcome mean values is observed between the implant groups for SSI but not
for the JFQ. (Table 2) When testing the possible association of implant failure measures and
other predictors with the SSI primary outcome, statistical significance (p<0.05) was found for
the presence of perforation (p=0.0279). The other predictors did not approach significance
(p>0.1). In regards to the JFQ primary outcome, the results showed no association with all the
specified predictors, including implant type. Following adjustment of the statistical models for
age and gender, significance (p<0.05) was again observed for the association between the
clinical outcome SSI and presence of perforation in the implant (p=0.0326). (Table 3)
In the full multivariate linear regression model for the SSI with all predictors entered, a
statistically significant association was found between the SSI and the presence of perforation,
SSI and the length of fracture, and SSI with age, thus indicating that age is an important
covariate. (Fig.8) The model for the JFQ revealed statistically significant results for length of
fracture, but age and gender were also important covariates. (Fig.8) Interestingly, while
searching for SSI symptom domains implicated in the association between the SSI and presence
of perforation, the Pain endurance component (which evaluates how disturbing the temple/ jaw
or jaw joint pain symptom is for the patient) was statistically related (p<0.05) to the above
implant failure measure (p=0.0148). (Fig.8)
DISCUSSION
Proplast/Teflon® IP showed specific patterns of polymeric breakdown such as perforation,
layer tearing and cleavage, and implant fiber extrusion. The presence of perforation and fracture
lines in these implants have also been reported in the literature.25,39,40 In contrast, the stereo
zoom observations for the Silastic® implants revealed structural breakdown features, such as
extensive fracture lines and less fiber extrusion. These characteristics for Silastic® IP have
been poorly described in the literature. Only one of the implants, a Proplast/Teflon® IP, had
remained intact with no signs of fracture, although a perforation was observed in its center.
The other 9 implants were fractured into more than one piece. These observations indicate that
these implants may not withstand the high TMJ vector forces. In regards to fracture length, no
obvious difference could be seen between the Proplast/Teflon® and Silastic® IPs. No Silastic®
IP showed a verifiable perforation. Although only three Proplast/Teflon® IPs had this failure
characteristic, suggesting that such presence of wear occurs mainly in this type of implant.
Some breakdown features could have been just a result from the implant surgical removal
procedures. Indeed, for certain implant specimens, the implant device was not totally complete,
possibly due to wear breakup and/or surgical procedure. The damage at the periphery of all
implants from the method of device fixation was rarely found. A large retrospective multicenter
study conducted by Spagnoli et al.25 reported that 44% of 96 removed Proplast/Teflon® IP
had gross observable wear signs and 14.6% were fractured. Additionally, 10.4% of the 96
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Proplast/Teflon® IP were found to be displaced in the TMJ, 9.4% were loose and 3.1% buckled;
suggesting lack of implant osteointegration, poor implant surgical fixation, use of aggressive
postoperative physical therapy, or high TMJ loading forces.25 The literature suggests that
preoperative extrinsic oral parafunctional activity, occlusal factors and intrinsic joint factors,
not be able to be controlled postoperatively, can lead to high TMJ loading and consequently
implant breakdown.25
Histomorphometric analysis showed osteointegration in the Proplast® porous matrix of the
PTE implants. Histological investigation complemented with clearly confirmed that fluorine
rich (Teflon) implant wear debris particles play apart in the multinucleated giant cell reaction
in the Proplast/Teflon® tissue samples. The size of these particles appeared to vary between
20 and 230 μm. The Trumpy et al.39 study showed aluminum particles in the tissues
surrounding the PTE implants, suggesting that these particles could be associated with the
FBGCR, but on our EMA no aluminum phase was found to be associated with FBGCR.
Particulate Teflon interaction studies by Zardeneta et al.67 suggest that the degree of biological
autoimmune response is proportionally related to the amount of serum protein adsorbed by
Teflon particles. Typically, a particle size of 50 μm or less in the Zardeneta study67 appeared
to dramatically increase the biological signals to local cell populations and activate cellular
cascades leading to inflammation. Surprisingly, this FBR was not observed by Zardeneta67 in
the Silastic® selected peri-implant soft tissues; only implant wear debris and non-associated,
scattered inflammatory cells were present. Moreover, Hartman et al.57 confirmed that
particulate silicon debris migrate to peri-implant TMJ fibrous pseudocapsular and lymph nodal
tissues, causing foreign body reaction, synovitis, dystrophic calcification, fibrocartilaginous
metaplasia, hyalinization, and scarring. Other studies by Shanbhag68 on the interaction
macrophage/implant particulate wear debris revealed a macrophage response dependent on the
particle size, composition and dose.
Electron Microprobe element mapping and line profile revealed the existence of two main
different chemical phases in the Proplast/Teflon® implants: calcium and phosphorus-rich. The
F and Al-rich material is most probably the Teflon layer, and the Ca-phosphate would be the
Proplast ceramic layer, confirming that the retrieved implant samples were Proplast/Teflon®
category II. Energy dispersive spectrometry revealed inclusions of several types of chemical
elements in these implant materials, which include: Fe, Fe-Cr, Bi-Al, NaCl, NaKCl, KAl
silicate, CaO phases. The presence of these potential toxic materials might be related with the
leftovers of the implant manufacturing process, and it confronts the prosthetic principles of
biocompatibility. In relation to the Silastic® implants, the element mapping and line profile
showed a silicon gel matrix with a fibrous material rich in F and contained an abundance of Ti
inclusions.
Statistical analysis showed a statistically significant correlation between the presence of
perforation and the SSI outcome. Furthermore, the presence of perforation was found to highly
predict the pain tolerability dimension of the SSI (p=0.0148). No apparent association was seen
between this implant failure predictor and the JFQ. These points to the fact that patients with
an implant perforation report increased pain symptoms and increased difficulty with enduring
the pain, but they do not have increased mandibular function impairment. Indeed these implant
patients tended to have very low JFQ scores for impairment. It should be emphasized that SSI
values varied greatly among the implant subjects. Given a sample of only 10 implants/patients,
this should be considered a pilot study. Nevertheless, the sample size needs to be increased in
future studies. After adjusting the linear models for age and gender, significance (p<.05) was
also observed for the association between one clinical outcome (SSI) and presence of
perforation in the implant (p=0.0326). The linear regression model for the SSI with all
predictors entered also showed that age could be an important predictor, depending on the
model.
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This pilot study demonstrated that pain was a significant correlate to perforation of the
alloplastic TMJ IP implants. This finding has been speculated elsewhere12,78 but it is
scientifically demonstrated here for the first time. Patients with these TMJ implants devices
report difficulties in tolerating their pain symptoms. Moreover, Teflon materials present in
these implants appeared to structurally fail and cause a FBGCR in the TMJ. The cause of this
breakdown may be multifactorial.
Stereo zoom microscopy may constitute a good quality technique to investigate biomechanical
failure patterns on the surface of implant devices. Electron Microprobe analysis (with line
profile and element mapping) can be an appropriate procedure to evaluate the surface of implant
devices, analyze the quality and quantity of different chemical phases present.
This pilot research also provided new information on the problems associated with past implant
materials, and these findings may assist in developing other appropriate types of TMJ implant
materials more resistant to perforation and breakage. These new TMJ materials should be
biocompatible and able to resist to TMJ biomechanical forces, without producing wear debris.
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TMJ PTE implant fragments observed in the stereo zoom microscope; a.Condylar smooth
fluorinated ethylene propylene (FEP) surface of a PTE implant (arrow indicates traces of
friction) (Magnification: 0.63X); b. Porous PTFE glenoid fossa surface with (*) perforation in
the center (Magnification: 0.63X); c. PTE implant with extruded fibers (arrows)
(Magnification: 4X); d. PTE fragment, smooth PTFE surface with attached osseous tissue
(arrow) (Magnification: 0,.63 X). PTFE: Polytetrafluorethylene.
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TMJ Silastic implant fragments observed in the stereo zoom microscope; a. TMJ Silastic
implant with a fracture line along its width (Magnification: 0.63X); b. TMJ Silastic implant
with several fracture lines (Magnification: 2X); c. TMJ Silastic implant with Dacron fiber
extrusion (Magnification: 4X).
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a. H&E histological sections of TMJ soft tissue attached to PTE implants. b. PTE implant
fragments (large arrow) surrounded by giant cells (small arrow) (H & E, Magnification: 200X);
Top Right: PTE implant fragments (large arrow) with bone ingrowth (arrow) on porous
Proplast surface (stained with Stevenel's blue and Van Gieson's picric fuchsin. Polarized light
with Magnification: 100X). c. H & E stained tissue sections from Silastic implant samples with
inflammatory infiltration (arrow). (Magnification: 200X)
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Backscattered electron image of PTE implant sample #2 with a labeled area for element
mapping and two line profiles (upper left). Element mapping images (upper right). Line profile
1 graph with Aluminum, Phosphorus, Calcium and Fluor x-ray counts (bottom).
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BSI of PTE implant section #3 with selected area for element mapping (left). Element mapping
images (right).
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Upper left corner: Selected H&% histological section for EMA showing a multinucleated
giant cell reaction to PTE implant fragment. (H & E. Magnification: 200X). Upper right
corner: BSI with a labeled Line profile. Bottom: Line profile graphs with Carbon (upper) and
Fluorine (bottom) x-ray counts.
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Silastic implant sample #8. Top: BSI of the Silastic implant (left). Element mapping images
(right). Bottom: BSI of same Silastic implant with a labeled line profile (left), and its
corresponding line profile graph with C, Si, F, N, and O x-ray counts (right).
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Top. p-values for JFQ to test what Predictors are related to this outcome measure. Bottom
Left. p-values for SSI to test what predictors (including age and gender variables) are possibly
related to this outcome measure. Bottom Right. Adjusted p-values (for age and gender) for all
SSI symptom domains to test what Predictors are related to these outcome domains.
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Table 2
Age (at time of explantation) and Gender distribution (in percentage), and means and standard deviations (SD) for
outcome measures by implant group








Proplast/Teflon® (PTE) N=7 50 (±13) 100% N=7 0.62 (0.24) 2.9 (2.6)
Silastic® (Si)* N=3 48 (±8) 66.7% N=2 0.40 (0.14) 2.5 (3.5)
NOTE: SD: Standard deviation.
*
The Silastic® implant encompasses the temporary/spacer and permanent types.
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Table 3
Adjusted p-values (for age and gender) to confirm if 3 Implant Predictors are statistically related to the SSI and JFQ.
Adjustments (Proc GLM procedure, SAS Institute) were made for age and gender.
Independent Variable/ Predictor Symptom Severity Index p-value Jaw Function Questionnaire p-value
Implant type 0.5212 (p>0.05) 0.4151 (p>0.05)
Presence of Perforation 0.0326 (p<0.05) 0.4991 (p>0.05)
Fracture Length 0.8496 (p>0.05) 0.3191 (p>0.05)
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